# Edwards EVOQUE Eos MISCEND Study

> **NCT02718001** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 123 (estimated)

## Conditions studied

- Mitral Valve Regurgitation (Degenerative or Functional)

## Interventions

- **DEVICE:** Edwards EVOQUE Eos Mitral Valve Replacement System

## Key facts

- **NCT ID:** NCT02718001
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-02-06
- **Primary completion:** 2028-04-30
- **Final completion:** 2033-04-30
- **Target enrollment:** 123 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718001, "Edwards EVOQUE Eos MISCEND Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02718001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*